Allena Pharmaceuticals, Inc.
ALNADelisted Sep 14, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001624658
Allena Pharmaceuticals, Inc. was delisted on Sep 14, 2022; its insiders filed their last Form 4 on Feb 2, 2022; 25 institutions reported holding it in 13F filings for Q2 2022, worth $1.71M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Allena Pharmaceuticals, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
ALNA is no longer listed, and 13F filings after Q2 2022 list far fewer holders. See Q2 2022
- Institutional holders
- 2
- −23 vs. Q2 2022
- Shares held
- 252.6K
- −8.70M (−97.2%) vs. Q2 2022
- Total value
- $4.00K
- −$1.70M (−99.8%) vs. Q2 2022
- New holders
- 0
- 0 more added
- Sold out
- 23
- 1 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALNA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 2 | $4.00K |
| Q2 2022 | 25 | $1.71M |
| Q1 2022 | 28 | $1.86M |
| Q4 2021 | 30 | $10.1M |
| Q3 2021 | 36 | $18.0M |
| Q2 2021 | 29 | $28.1M |
| Q1 2021 | 30 | $28.3M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Allena Pharmaceuticals, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Acadian Asset Management LLC | 237,610 | $4.00K | 0.00% | −1,013,378−81.0% | Reduced |
| 1620 Investment Advisors, Inc. | 15,000 | $0 | 0.00% | 00.0% | Unchanged |
| TRV GP II, LLC | 0 | $0 | 0.00% | −2,790,964−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −2,682,145−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −386,352−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −357,044−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −228,215−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −205,058−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −174,988−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −173,798−100.0% | Sold out |
| Kestra Advisory Services, LLC | 0 | $0 | 0.00% | −164,662−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −106,183−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −89,363−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −83,827−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −65,789−100.0% | Sold out |
| Level Four Advisory Services, LLC | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −30,550−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −33,000−100.0% | Sold out |
| Golden Green, Inc. | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −17,200−100.0% | Sold out |
| Prospera Financial Services Inc | 0 | $0 | 0.00% | −10,800−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −10,053−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −5,800−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −3,053−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −6−100.0% | Sold out |